Did the UK Court of Appeals Make Excessive Pricing Claims Easier?
In Pfizer/Flynn (Phenytoin II), the Court of Appeal closed one of UK…
Appeal Court Restores CMA Victory Over Pharma Pricing
The UK Court of Appeal has completely overturned a lower tribunal's intervention,…
Financial Literacy as a Litigation Strategy: Lessons from Apple and Google
Recent rulings from the UK’s Competition Appeal Tribunal (CAT) show that regulators…
Pfizer to Acquire Obesity Drug Developer Metsera for $10B, Winning Bidding War Against Denmark’s Novo Nordisk
Pfizer announced it has agreed to acquire the obesity drug developer Metsera…
Robust, but Incomplete: Inside the CMA’s Profitability Analysis of Google
When the UK’s Competition and Markets Authority confirmed Google’s Strategic Market Status…
Pfizer’s $25.5 Million Effexor XR Antitrust Settlement Marks Turning Point in Long-standing Legal Battle
The Effexor XR Antitrust Litigation, centered around allegations of collusion between pharmaceutical…